Development of the myogenic response in postnatal intestine: role of PKC.
Previous attempts to determine developmental changes in the vascular myogenic response have been confounded by the presence of competing vasoactive stimuli or the use of isolated vessels with markedly different baseline diameters. To circumvent these issues, small mesenteric arteries (diameter approximately 150 microm) from 1- and 10-day-old piglets were studied in vitro under no-flow conditions. In situ studies demonstrated that the intravascular pressure and diameter of these vessels were similar in both age groups, allowing an effective comparison of the myogenic response not obscured by differences in basal diameter. The pressure-diameter relationship was age specific. Thus, although small mesenteric arteries from both age groups demonstrated myogenic constriction in response to stepwise increases in pressure (0 to 100 mmHg, in 20-mmHg increments), the intensity of contraction was significantly greater in vessels from 1-day-old piglets particularly within the pressure range normally experienced by these vessels in situ. Attenuation or activation of PKC with calphostin C or indolactam, respectively, substantially altered the pressure-diameter relationship in 1-, but not 10-day-old arteries; thus calphostin C essentially eliminated the contractile response to pressure elevation in younger subjects, whereas indolactam significantly increased the intensity of the myogenic response and shifted its activation point to a lower pressure range. Immunoblots carried out on protein recovered from these arteries revealed the presence of alpha, beta, epsilon, iota, and lambda; notably, expression of the alpha- and epsilon-isoforms substantially decreased between postnatal days 1 and 10.
Su
Baogen Y
BY
Children's Research Institute, Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA.
Reber
Kristina M
KM
Nankervis
Craig A
CA
Nowicki
Philip T
PT
D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D015153:Blotting, Western; D004791:Enzyme Inhibitors / Q000494:pharmacology; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology; D007422:Intestines / Q000098:blood supply / Q000502:physiology*; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000378:metabolism; D007769:Lactams / Q000494:pharmacology; D008638:Mesenteric Arteries / Q000033:anatomy & histology / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000502:physiology*; D009281:Naphthalenes / Q000494:pharmacology; D011312:Pressure; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000502:physiology*; D012039:Regional Blood Flow / Q000502:physiology; D013552:Swine; D014661:Vasoconstriction / Q000502:physiology*
D004791:Enzyme Inhibitors; D007211:Indoles; D007527:Isoenzymes; D007769:Lactams; D009281:Naphthalenes; C043969:indolactam V; D011493:Protein Kinase C; C058819:calphostin C